Conflict noted between African scientists

Mar 08, 2007

A conflict between scientists working with the human immunodeficiency virus and those working with tuberculosis is being reported in Africa.

The controversy stems from the fact TB is the leading cause of death among those infected with HIV and, in some African countries, about 60 percent of those with TB are also HIV-positive.

Although there are serious drug interactions between HIV and TB medicines, physicians are also finding a deadly new syndrome called IRIS, which results when those with TB are put on HIV medicines.

Yet, observers note, the two communities continue to work separately, diagnosing and treating one disease without taking the other into account. Adding to the problem is the fact TB researchers receive less than 10 percent of the funding given to HIV-AIDS scientists annually.

And since existing drugs and vaccines for tuberculosis were developed decades ago, the TB infrastructure needs to be updated. But without needed funding, researchers are struggling to find new drugs and vaccines.

The controversy is detailed in a special report appearing in this month's issue of the New York-published journal Nature Medicine.

Copyright 2007 by United Press International

Explore further: Liver transplant recipient marks 25th anniversary

add to favorites email to friend print save as pdf

Related Stories

Recommended for you

Doctor behind 'free radical' aging theory dies

Nov 25, 2014

Dr. Denham Harman, a renowned scientist who developed the most widely accepted theory on aging that's now used to study cancer, Alzheimer's disease and other illnesses, has died in Nebraska at age 98.

Mexican boy who had massive tumor recovering

Nov 25, 2014

An 11-year-old Mexican boy who had pieces of a massive tumor removed and who drew international attention after U.S. officials helped him get treatment in the southwestern U.S. state of New Mexico is still recovering after ...

New medical device to make the mines safer

Nov 21, 2014

Dehydration can be a serious health issue for Australia's mining industry, but a new product to be developed with input from Flinders University's Medical Device Partnering Program (MDPP) is set to more effectively ...

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.